Zions Bancorporation’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.42M Buy
116,916
+17,119
+17% +$239K 0.09% 190
2024
Q3
$1.68M Buy
99,797
+17,752
+22% +$292K 0.12% 152
2024
Q2
$1.28M Buy
82,045
+15,008
+22% +$209K 0.1% 159
2024
Q1
$1.06M Buy
67,037
+4,055
+6% +$67.9K 0.08% 200
2023
Q4
$1.27M Buy
62,982
+3,248
+5% +$55K 0.09% 183
2023
Q3
$1.11M Buy
59,734
+16,688
+39% +$363K 0.1% 169
2023
Q2
$936K Buy
43,046
+570
+1% +$10.3K 0.08% 190
2023
Q1
$787K Buy
+42,476
New +$798K 0.07% 212

Other funds holding NEOG

Zions Bancorporation's NEOG Position: Q4 2024 in Review

Zions Bancorporation increased its Neogen (NEOG) stake by 17% in Q4 2024, buying an estimated $239K and bringing the position to 116,916 shares worth $1.42M. The position accounts for 0.09% of the portfolio, ranked #190.

Zions Bancorporation first reported a position in NEOG in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.68M in Q3 2024. 343 funds tracked by Wall St. Rank hold NEOG as of Q4 2024.

  • Zions Bancorporation held 116,916 shares of Neogen worth $1.42M as of Q4 2024.
  • Zions Bancorporation bought 17,119 Neogen shares in Q4 2024, an estimated $239K.
  • Neogen made up 0.09% of Zions Bancorporation's portfolio in Q4 2024, its #190 holding.
  • Zions Bancorporation first reported a position in Neogen in Q1 2023 and has held it in 8 quarters since.
  • Zions Bancorporation's Neogen position peaked at $1.68M in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Neogen as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.